1. A systematic review and critical evaluation of reported pathogenic sequence variants in hidradenitis suppurativa. (1st October 2017) Authors: Frew, J.W.; Vekic, D.A.; Woods, J.; Cains, G.D. Journal: British journal of dermatology Issue: Volume 177:Number 4(2017) Page Start: 987 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A systematic review and critical evaluation of reported pathogenic sequence variants in hidradenitis suppurativa. (20th September 2017) Authors: Frew, J.W.; Vekic, D.A.; Woods, J.; Cains, G.D. Journal: British journal of dermatology Issue: Volume 177:Number 4(2017) Page Start: 987 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Amplicon sequencing demonstrates comparable follicular mycobiomes in patients with hidradenitis suppurativa compared with healthy controls. (22nd March 2022) Authors: Ring, H.C.; Thorsen, J.; Fuursted, K.; Bjarnsholt, T.; Bay, L.; Egeberg, A.; Ingham, A.C.; Vedel Nielsen, H.; Frew, J.W.; Saunte, D.M.L.; Thomsen, S.F.; Jemec, G.B. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 7(2022) Page Start: e580 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Antimicrobial peptides in hidradenitis suppurativa: a systematic review. (1st February 2022) Authors: Yao, Y.; Frew, J.W.; Thomsen, S.F.; Ring, H.C. Journal: British journal of dermatology Issue: Volume 186:Number 2(2022) Page Start: 236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Antimicrobial peptides in hidradenitis suppurativa: a systematic review. (2nd November 2021) Authors: Yao, Y.; Frew, J.W.; Thomsen, S.F.; Ring, H.C. Journal: British journal of dermatology Issue: Volume 186:Number 2(2022) Page Start: 236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Assessing the efficacy of new biologic therapies in hidradenitis suppurativa: consistency vs. bias in outcome measures in moderate and severe disease. (1st April 2019) Authors: Frew, J.W. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 8(2019) Page Start: e298 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Assessing the responsiveness of sonographic biomarkers to Brodalumab therapy in Hidradenitis Suppurativa. (18th August 2021) Authors: Frew, J.W.; Grand, D.; Navrazhina, K.; Garcet, S.; Krueger, J.G. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 12(2021) Page Start: e884 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Beyond the tip of the iceberg: the role of phosphoinositide 3‐kinase/AKT in acne inversa/hidradenitis suppurativa. (1st March 2016) Authors: Frew, J.W. Journal: British journal of dermatology Issue: Volume 174:Number 3(2016) Page Start: 484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Beyond the tip of the iceberg: the role of phosphoinositide 3‐kinase/AKT in acne inversa/hidradenitis suppurativa. (March 2016) Authors: Frew, J.W. Journal: British journal of dermatology Issue: Volume 174:Number 3(2016) Page Start: 484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. BJD research letters: concise, thought provoking and of general interest. (14th February 2018) Authors: Frew, J.W.; Anstey, A. Journal: British journal of dermatology Issue: Volume 178:Number 2(2018) Page Start: 309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗